H. Lawrence Remmel - 26 Mar 2025 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
Director
Signature
/s/ H. Lawrence Remmel
Issuer symbol
ATOS
Transactions as of
26 Mar 2025
Net transactions value
+$7,000
Form type
4
Filing time
28 Mar 2025, 16:00:03 UTC
Previous filing
01 Jul 2024
Next filing
16 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATOS Common Stock Purchase $7,000 +10,000 +3891% $0.7000 10,257 26 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a reverse stock split of the Issuer's common stock at a ratio of 12:1 effective April 2018. The Reporting Person disclaims beneficial ownership of 11 shares of common stock owned by his spouse except to the extent of his pecuniary interest in the shares.